Don’t Miss TipRanks’ Half Year Sale
- Take advantage of TipRanks Premium for 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) has shared an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company, through its subsidiary GP Corp., has entered into a Completion Confirmation Letter with Industrial Securities Asset Management to dispose of accounts receivable valued at RMB401,493,434.77. This transaction, part of a series of similar transactions within a 12-month period, is considered a disclosable transaction under the Hong Kong Stock Exchange Listing Rules, requiring reporting and announcement but not shareholder approval.
The most recent analyst rating on (HK:0874) stock is a Hold with a HK$25.40 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Average Trading Volume: 1,401,444
Technical Sentiment Signal: Sell
Current Market Cap: HK$44.95B
See more data about 0874 stock on TipRanks’ Stock Analysis page.